19,246 Shares in CVS Health Corp (NYSE:CVS) Acquired by WFA of San Diego LLC

Share on StockTwits

WFA of San Diego LLC bought a new position in shares of CVS Health Corp (NYSE:CVS) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 19,246 shares of the pharmacy operator’s stock, valued at approximately $1,435,000.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in the stock. Rodgers Brothers Inc. boosted its position in CVS Health by 0.7% during the second quarter. Rodgers Brothers Inc. now owns 23,521 shares of the pharmacy operator’s stock worth $1,528,000 after acquiring an additional 154 shares during the last quarter. Insight Wealth Strategies LLC boosted its holdings in shares of CVS Health by 4.7% in the 2nd quarter. Insight Wealth Strategies LLC now owns 3,666 shares of the pharmacy operator’s stock valued at $238,000 after purchasing an additional 165 shares during the last quarter. CWA Asset Management Group LLC boosted its holdings in shares of CVS Health by 1.6% in the 1st quarter. CWA Asset Management Group LLC now owns 11,055 shares of the pharmacy operator’s stock valued at $656,000 after purchasing an additional 175 shares during the last quarter. Roosevelt Investment Group Inc. boosted its holdings in shares of CVS Health by 1.0% in the 2nd quarter. Roosevelt Investment Group Inc. now owns 18,346 shares of the pharmacy operator’s stock valued at $1,192,000 after purchasing an additional 175 shares during the last quarter. Finally, Estabrook Capital Management boosted its holdings in shares of CVS Health by 5.0% in the 2nd quarter. Estabrook Capital Management now owns 3,650 shares of the pharmacy operator’s stock valued at $237,000 after purchasing an additional 175 shares during the last quarter. Hedge funds and other institutional investors own 75.88% of the company’s stock.

CVS Health stock traded down $0.60 during midday trading on Friday, hitting $57.40. 11,589,614 shares of the stock were exchanged, compared to its average volume of 7,136,621. The company has a debt-to-equity ratio of 0.93, a current ratio of 0.98 and a quick ratio of 0.72. CVS Health Corp has a 1 year low of $52.04 and a 1 year high of $77.03. The company has a 50 day moving average price of $63.26 and a two-hundred day moving average price of $62.61. The firm has a market cap of $75.12 billion, a P/E ratio of 9.13, a P/E/G ratio of 1.42 and a beta of 0.67.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, August 5th. The pharmacy operator reported $2.64 earnings per share for the quarter, beating analysts’ consensus estimates of $1.93 by $0.71. CVS Health had a net margin of 3.13% and a return on equity of 16.32%. The business had revenue of $65.30 billion during the quarter, compared to the consensus estimate of $64.29 billion. During the same quarter in the prior year, the firm earned $1.89 EPS. The company’s revenue for the quarter was up 2.9% compared to the same quarter last year. As a group, analysts predict that CVS Health Corp will post 7.23 EPS for the current year.

A number of equities analysts have weighed in on the stock. Royal Bank of Canada reiterated a “buy” rating on shares of CVS Health in a report on Thursday, July 9th. SVB Leerink lifted their price target on shares of CVS Health from $72.00 to $73.00 and gave the company a “market perform” rating in a report on Thursday, August 6th. Credit Suisse Group lifted their price target on shares of CVS Health from $75.00 to $90.00 and gave the company an “outperform” rating in a report on Friday, August 7th. Finally, Deutsche Bank reduced their target price on shares of CVS Health from $109.00 to $104.00 and set a “buy” rating on the stock in a report on Thursday, August 6th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, twelve have issued a buy rating and two have issued a strong buy rating to the company. CVS Health has an average rating of “Buy” and a consensus price target of $82.60.

About CVS Health

CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services.

Read More: Balance Sheet

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply